Phase II Pilot Study of Imatinib Mesylate for the Treatment of Severe Sclerotic Skin Chronic Graft Versus Host Disease (ScGVHD) by Baird, K, Booher, S, Comis, L.E, Joe, G.O, Steinberg, S.M, Spencer, S.D, Figg, W.D, Takebe, N, Pavletic, S.Z, Cowen, E.W

Get full text

NHANES III Equations for PFT Interpretation Significantly Alters BOS Diagnoses, Severity, and Prognosis After Hematopoietic Stem Cell Transplantation (HSCT) by Williams, K.M, Hnatiuk, O, Steinberg, S.M, Mitchell, S, Baird, K, Gadalla, S.M, Carpenter, A, Avila, D, Taylor, T, Urban, A, Comis, L.E, Blacklock-Schuver, B, Gress, R.E, Pavletic, S.Z

Get full text

Preliminary Results Of A Phase II Trial Of Montelukast For The Treatment Of Bronchiolitis Obliterans Syndrome After HSCT by Williams, K.M, Pavletic, S.Z, Hakim, F.T, Mitchell, S.A, Gea-Banacloche, J.C, Comis, L.E, Cowen, E.W, Baird, K, Louie, A, Shelhamer, J.H, Blacklock-Schuver, B.A.J, Avila, D, Carpenter, A, Gress, R.E

Get full text

National Institutes of Health (NIH) Chronic GVHD Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Progn... by Baird, K., Steinberg, S.M., Grkovic, L., Pulanic, D., Cowen, E.W., Mitchell, S.A., Williams, K.M., Datiles, M.B., Bishop, R., Bassim, C.W., Mays, J.W., Edwards, D., Cole, K., Avila, D.N., Taylor, T., Urban, A., Joe, G.O., Comis, L.E., Berger, A., Stratton, P., Zhang, D., Shelhamer, J.H., Gea-Banacloche, J.C., Sportes, C., Fowler, D.H., Gress, R.E., Pavletic, S.Z.

Get full text